[Over the weekend Gilead presented results from its combination of sofosbuvir and daclatasvir that cured between 98 and 100 percent of patients within 12 weeks.]
Are they assuming that DACLATASVIR belongs to GILEAD? Did Gilead buy Bristol-Myers too?
The trial for 7977+BMS790052(=Daclatasvir) had 3 arms, and all 3 arms dosed the dual or triple (the 3rd was Riba) combos that lasted 24 weeks, not 12weeks! Where do they get the news?
Gilead is now developing 7977+5885, and decided not to develop 7977+Daclatasvir combo.
I echoed you guys sentiment here. Was once an investor in this stock before Telaprevir got approval. We longs in ACHN are also frustrated as almost every Analyst out there focus on GILD....as far as that Micheal Yee 's statement regarding Gilead one pill cure all; I have to say #$%$ has he been smoking as of late.